Jonathan Krinsky, BTIG chief market technician, joins 'Money Movers' to discuss his bullish call for this small sector to ...

This decision came after the full FDA approval of YUTREPIA inhalation powder for adults with pulmonary arterial hypertension ...

Russell 2000 nears breakout after a 7-month downtrend. Discover key sector inflection points & 5 small-cap stocks poised for ...

Investing.com -- BTIG upgraded Doximity Inc (NYSE: DOCS) to Buy from Neutral and set a price target of $80, saying recent ...

Shake Shack (SHAK) stock drops after BTIG downgrades to Neutral, citing concerns over guest frequency and valuation.

On June 4, analysts at BTIG reiterated a Buy rating and maintained a $210 price target on Chart Industries Inc. (NYSE:GTLS).

LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that management will be participating in the following investor conferences during the month of June: ...

On Tuesday, BTIG analysts reaffirmed their Buy rating on Theravance Biopharma stock (NASDAQ: NASDAQ:TBPH), maintaining a price target of $24.00, representing a potential 115% upside from the ...

On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business. The analyst did not assign a price target following ...

Caris Life Sciences, which is backed by Sixth Street and JH Whitney, has filed for an IPO. Headquartered in Irving, Texas, Caris Life Sciences is a medical tech company. The IPO price is expected to ...

Detailed price information for Veeva Systems Inc (VEEV-N) from The Globe and Mail including charting and trades.